15 results
424B3
SYRS
Syros Pharmaceuticals Inc.
8 Aug 22
Prospectus supplement
5:47pm
submits;
recall of products;
damage to relationships with collaborators;
unfavorable press coverage and damage to Syros’ reputation;
fines … restrictions on the drug or its manufacture and requiring Tyme to recall or remove the drug from the market. The regulators could also suspend
S-4
SYRS
Syros Pharmaceuticals Inc.
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
;
recall of products;
damage to relationships with collaborators;
unfavorable press coverage and damage to Syros’ reputation;
fines, restitution … on Tyme, imposing restrictions on the drug or its manufacture and requiring Tyme to recall or remove the drug from the market. The regulators could also
10-K
netv19y
20 Mar 17
Annual report
12:00am
- Prev
- 1
- Next